alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal C 401/13 N

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 401 |
| | |
| English edition | Information and Notices | Volume 5713 November 2014 |

ISSN 1977-091X

Official Journal

of the European Union

C 401

English edition

Information and Notices

Volume 5713 November 2014

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| 2014/C 401/01 | Annual accounts of the 8th, 9th and 10th European Development Funds — Financial year 2013 | 1 |
| 2014/C 401/02 | The Court’s Statement of Assurance on the 8th, 9th and 10th EDFs to the European Parliament and the Council — Independent auditor’s report | 264 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

2014/C 401/01

Annual accounts of the 8th, 9th and 10th European Development Funds — Financial year 2013

1

2014/C 401/02

The Court’s Statement of Assurance on the 8th, 9th and 10th EDFs to the European Parliament and the Council — Independent auditor’s report

264

---

| EN | |
| --- | --- |

EN
Exhibit 32.2

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Inovalon Holdings, Inc. (the "Company") on Form 10-K for the period ended
December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas R. Kloster, Chief Financial Officer of the Company, certify, to my knowledge,
pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



/s/ THOMAS R. KLOSTER Thomas R. Kloster Chief Financial Officer


Date:
March 31, 2015

---



QuickLinks
III

104TH CONGRESS

1ST SESSION S. RES. 146

Designating the week beginning November 19, 1995, and the week beginning

on November 24, 1996, as ‘‘National Family Week’’, and for other purposes.

IN THE SENATE OF THE UNITED STATES

JUNE 30 (legislative day, JUNE 19), 1995

Mr. JOHNSTON submitted the following resolution; which was referred to the

Committee on the Judiciary

RESOLUTION

Designating the week beginning November 19, 1995, and

the week beginning on November 24, 1996, as ‘‘National

Family Week’’, and for other purposes.

Whereas the family is the basic strength of any free and orderly society;

Whereas it is appropriate to honor the family as a unit essential to the continued well-being of the United States; and

Whereas it is fitting that official recognition be given to the

importance of family loyalties and ties: Now, therefore,

be it

1 Resolved, That the Senate designates the week begin2 ning on November 19, 1995, and the week beginning on

3 November 24, 1996, as ‘‘National Family Week’’. The
2

•SRES 146 IS

1 Senate requests the President to issue a proclamation call2 ing on the people of the United States to observe each

3 week with appropriate ceremonies and activities.

Æ
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 1**  **0 -**  **1474**

I n R e: VICTOR WARDELL WRIGHT , Petitioner.

On Petition for Writ of Mandamus

. ( 8:06

- cr - 00038

- DKC

- 1; 8:08

- cv - 02830

- DKC )

Submitted : July 22, 2010 Decided: July 30, 2010

Before NIEMEYER, GREGORY, and SHEDD , Circuit Judges.

Petition denied by un published per curiam opinion

. Victor Wardell Wright , Petitioner Pro Se.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Victor Ward ell Wright petitions for a writ of mandamus, alleging the district court has unduly delayed acting on his 28 U.S.C.A. § 2255 (West Supp. 2010) motion for a writ of habeas corpus . He seeks an order from this court directing the district court to act. Our review of the district court’s docket reveals that the district court denied Wright’s motion on May 26, 2010 **.** Accordingly, because the district court has recently decided Wright ’ s case, we deny the mandamus petition as moot. We grant leave to proceed in forma pauperis. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.
PETITION DENIED
**EXHIBIT 32.2**

 

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

(18 U.S.C. 1350)

 

The undersigned, Sterling H.McDonald, Vice-President and Chief Financial Officer of Evolution PetroleumCorporation (the “Company”), certifies in connection with the filing with theSecurities and Exchange Commission of the Company’s Quarterly Report on Form 10-Qfor the quarter ended September 30, 2009 (the “Report”) pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, to his knowledge, that:

 

1. The Report fully complieswith the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2. The information containedin the Report fairly presents, in all material respects, the financialcondition and results of operations of the Company.

 

IN WITNESS WHEREOF, theundersigned has executed this certification as of the 13th day of November,2009.

 
|   | /s/ STERLING H. MCDONALD                    |
|--------|---------------------------------------------|
|   | Sterling H. McDonald                        |
|   | Vice-President and Chief  Financial Officer |

 

A signed original of thiswritten statement required by Section 906 has been provided to EvolutionPetroleum Corporation and will be retained by Evolution Petroleum Corporationand furnished to the Securities and Exchange Commission or its staff uponrequest.  The foregoing certificate isbeing furnished to the Securities and Exchange Commission as an exhibit to thisForm 10-Q and shall not be considered filed as part of the Form 10-Q.

 

----
```

[Federal Register Volume 87, Number 48 (Friday, March 11, 2022)]
[Notices]
[Page 14004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05321]

=======================================================================
-----------------------------------------------------------------------

EXPORT-IMPORT BANK

Sunshine Act Meetings

TIME AND DATE: Tuesday, March 29th, 2022 from 2:00-4:30 p.m. ET.

PLACE: The meeting will be held virtually.

STATUS: Public Participation: The meeting will be open to public 
participation and time will be allotted for questions or comments 
submitted online. Members of the public may also file written 
statements before or after the meeting to [email protected]. Interested 
parties may register below for the meeting: https://teams.microsoft.com/registration/PAFTuZHHMk2Zb1GDkIVFJw,5M1LfonJMEi2VFUgYRv6oQ,i145n2l9vkmDj5btNlkuGw,Zk6gqBB9XU2B7MJxTkDJAA,AS8JU-QbJUq_3I7uXiqo3w,ui5BwrlZVkGa7D1F2otyIg?mode=read&tenantId=b953013c-c791-4d32-996f-518390854527.

MATTERS TO BE CONSIDERED: Discussion of EXIM policies and programs to 
provide competitive financing to expand United States exports and 
comments for inclusion in EXIM's Report to the U.S. Congress on Global 
Export Credit Competition.

CONTACT PERSON FOR MORE INFORMATION: For further information, contact 
India Walker, External Enagagement Specialist, at 202-480-0062 or at 
[email protected].

Joyce B. Stone,
Assistant Corporate Secretary.
[FR Doc. 2022-05321 Filed 3-9-22; 4:15 pm]
BILLING CODE 6690-01-P
```
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

DAVID A. CALHOUN,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 113 EAL 2023

Petition for Allowance of Appeal

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 19th day of September, 2023

, the Petition for Allowance of Appeal

is DENIED

.
```

[Federal Register Volume 87, Number 56 (Wednesday, March 23, 2022)]
[Notices]
[Pages 16497-16498]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06162]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-984]

Bulk Manufacturer of Controlled Substances Application: Siemens 
Healthcare Diagnostics, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics, Inc. has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
May 23, 2022. Such persons may also file a written request for a 
hearing on the application on or before May 23, 2022.

ADDRESSES: The Drug Enforcement Administration (DEA) requires that all 
comments be submitted electronically

[[Page 16498]]

through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the web page or 
attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for 
submitting comments. Upon submission of your comment, you will receive 
a Comment Tracking Number. Please be aware that submitted comments are 
not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment.''

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 17, 2022, Siemens Healthcare Diagnostics 
Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702-2461, applied 
to be registered as a bulk manufacturer of the following basic 
class(es) of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Ecgonine...............................    9180  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substance in 
bulk to be used in the manufacture of DEA exempt products. No other 
activities for these drug codes are authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-06162 Filed 3-22-22; 8:45 am]
BILLING CODE P
```
No. 12-5021.

#### Cook *v.*Gipson, Acting Warden.

C. A. 9th Cir. Motion of petitioner for leave to proceed *in forma pauperis*denied, and certiorari dismissed. See this Court’s Rule 39.8. As petitioner has repeatedly abused this Court’s process, the Clerk is directed not to accept any further petitions in noncriminal matters from petitioner unless the docketing fee required by Rule 38(a) is paid and the petition is submitted in compliance with Rule 33.1. See *Martin*v. *District of Columbia Court of Appeals,*506 U. S. 1 (1992) *(per curiam).*
Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Long Island Physician Holdings
Corporation (the "Company") on Form 10-Q for the period ended June 30, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Paul Kolker, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

/s/ Paul Kolker
---------------
Paul Kolker,
President, Chairman of the Board
(Principal Executive Officer)

Date: _______________________

      This certification accompanies the above-described Report on Form 10-Q
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except
to the extent required by such Act, be deemed filed by the Company for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended.


                                       19
<PAGE>

                         CESSION OF SHAREHOLDER'S LOAN

                            MEMORANDUM OF AGREEMENT

                              entered into between

                           RANDGOLD RESOURCES LIMITED

                       (hereinafter called "the cedent")

                                      and

                       ANGLOGOLD MORILA HOLDINGS LIMITED

                     (hereinafter called "the cessionary")

WHEREAS the cedent has sold 50% of the entire issued share capital of Randgold
Resources (Morila) Limited ("(Morila) Limited") together with 50% of the total
amount owing by Societe des Mines de Morila S.A. ("Morila S.A.") to the
cessionary ("the Shareholders' Loan") in terms of a Sale of Shares agreement
dated 29 May 2000;

AND WHEREAS the cessionary has undertaken to pay the purchase price upon the
cedent fulfilling undertakings made by it in terms of the Sale of Shares
agreement;

AND WHEREAS the cedent, (Morila) Limited, and Morila S.A. entered into a loan
agreement in respect of monies lent by the cedent to Morila S.A. and which
monies are the subject of the Shareholders Loan, on 21 December 1999.

NOW THEREFORE IT IS AGREED as follows:

1.     CESSION

       The cedent hereby cedes, transfers and makes over to the cessionary its
       right, title and interest in and to the Shareholders' Loan as at the date
       hereof.

2.     ACCEPTANCE

       The cessionary hereby accepts the said cession.

SIGNED at Johannesburg on this 3rd day of July 2000.

Witnesses

1.  /s/ [ILLEGIBLE]
    _________________________

2.  /s/ [ILLEGIBLE]                                 /s/ [ILLEGIBLE]
    _________________________                       ____________________________
    (Signatures of witnesses)                        RANDGOLD RESOURCES LIMITED

SIGNED at Johannesburg on this 3rd day of July 2000.

Witnesses:

1.  /s/ [ILLEGIBLE]
    _________________________

2.  /s/ [ILLEGIBLE]                                 /s/ [ILLEGIBLE]
    _________________________                       ____________________________
    (Signatures of witnesses)                        ANGLOGOLD MORILA HOLDINGS
                                                               LIMITED
#### UNITED STATES of America, Plaintiff-Appellee, v. Winston R. IRONS, a/k/a Tony, Defendant-Appellant.

No. 17-7021

United States Court of Appeals, Fourth Circuit.

Submitted: December 29, 2017

Decided: January 18, 2018

Winston R. Irons, Appellant Pro Se. Andrew R. Cogar, Assistant United States Attorney, Traci Michelle Cook, OFFICE OF THE UNITED STATES ATTORNEY, Clarksburg, West Virginia, for Ap-pellee.

*186Before KING, AGEE, and FLOYD, Circuit Judges.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Winston R. Irons seeks to appeal the district court’s order adopting the recommendation of the magistrate judge and denying relief on his 28 U.S.C. § 2255 (2012) motion. In a civil case in which the United States is a party, the notice of appeal must be filed within 60 days after entry of judgment. Fed. R. App. P. 4(a)(1)(B). “[T]he timely filing of a notice of appeal in a civil case is a jurisdictional requirement.” *Bowles v. Russell,*551 U.S. 205, 214, 127 S.Ct. 2360, 168 L.Ed.2d 96 (2007).

Because Irons is incarcerated, the notice of appeal is considered filed on the date it was properly delivered to prison officials for mailing to the court. Fed. R. App. P. 4(c)(1); *Houston v. Lack,*487 U.S. 266, 267, 108 S.Ct. 2379, 101 L.Ed.2d 245 (1988). The record does not conclusively reveal when Irons delivered the notice of appeal to prison officials for mailing. Accordingly, we remand the case for the limited purpose of allowing the district court to obtain this information from the parties and to determine whether the filing was timely under Fed. R. App. P. 4(c)(1) and *Houston v. Lack.*The record, as supplemented, will then be returned to this court for further consideration.

*REMANDED*
Exhibit 5

                                  Certification

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Long Island Physician Holdings
Corporation (the "Company") on Form 10-Q for the period ended March 31, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Concetta Pryor, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

/s/ Concetta Pryor
------------------
Concetta Pryor
Chief Financial Officer
May 14, 2004

      This certification accompanies the above-described Report on Form 10-Q
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except
to the extent required by such Act, be deemed filed by the Company for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of PowerHouse Technologies Group, Inc.
(the "Company") on Form 10-QSB for the period ended December 31, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Jay Elliot, Chairman of the Board and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and result of operations
            of the Company.


/s/ Jay Elliot
-----------------
Jay Elliot
Chairman of the Board and Chief Executive Officer
Date: March 26, 2004
Exhibit 31.2

CERTIFICATION

I,
Thomas R. Kloster, certify that:

1.     I
have reviewed this annual report on Form 10-K of Inovalon Holdings, Inc.;

2.     Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



5.     The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



/s/ THOMAS R. KLOSTER Thomas R. Kloster Chief Financial Officer


Date:
March 31, 2015

---



QuickLinks
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
 Washington, D.C. 20549
 Amendment No. 2
to  FORM 10-Q
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 For the quarterly period ended September 30, 2009
 Commission File No: 0-27848
 BIOFIELD CORP.
  Delaware
    
    13-3703450(State of other jurisdiction of Incorporation or Organization)
    
    (Employer Identification Number)175 Strafford Avenue, Suite 1, Wayne, PA
    
    19087(Address of principal executive offices)
    
    (Zip Code)
 
 Yes þ No o
 Yes o No þ
  Large Accelerated Filer
    
    o
    
    Accelerated Filer
    
    oNon-Accelerated Filer
    
    o
    
    Smaller Reporting Company
    
    þ
 Yes o No þ
 AS OF NOVEMBER 13, 2009, THERE WERE 36,261,833 SHARES OF COMMON STOCK OUTSTANDING AND 12,300,000
SHARES OF VOTING PREFERRED STOCK OUTSTANDING.




---



##### 



EXPLANATORY NOTE




---



##### 



SIGNATURES
  BIOFIELD CORP.Date: February 1, 2010
    By:
    /s/  David Bruce HongDavid Bruce HongChief Executive OfficerBy:
    /s/  David Bruce HongDavid Bruce HongChief Financial Officer